Standardized assay for assessment of minimal residual disease in blood, bone marrow and apheresis from patients with plasma cell myeloma

Scientific Reports
Agnieszka BlumLutz Uharek

Abstract

The recent advances in myeloma treatment result in significantly better outcomes, defined as increased progression free survival (PFS) and overall survival (OS). Since there is a proven correlation between the extend of response and prolonged survival, there is an urgent need for highly sensitive assays for the detection of minimal residual disease (MRD). Next generation flow cytometry has become a valuable approach for sensitive evaluation of the depth of complete response (CR). Here, we report the diagnostic performance and validation results of a single-tube 9-color panel assay. The validation design included intra-assay analysis measuring accuracy, inter-assay analysis estimating method's linearity and precision and inter-assay analysis evaluating repeatability. Furthermore, in inter-operator analysis assessed the comparability of the result analysis of different operators. Staining stability was evaluated in age-of-stain experiments. Our validation results show that a reliable detection of residual myeloma cells is feasible to a detection level of 10-5 with a single-tube assay for a variety of materials (peripheral blood, bone marrow and stem cell apheresis). This study establishes highly sensitive, fully standardized appr...Continue Reading

References

Jun 1, 1996·Current Opinion in Immunology·G M DoodyD T Fearon
Oct 1, 1996·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·K MehtaF Malavasi
Nov 14, 1997·The Biochemical Journal·D J Carey
Jun 20, 2002·Trends in Immunology·A Neil BarclayMarion H Brown
Jun 28, 2005·BMC Immunology·Holden T MaeckerRafick P Sekaly
Jan 7, 2006·Pharmaceutical Research·Jean W LeeJohn A Wagner
Dec 1, 2011·Blood·Bruno PaivaUNKNOWN PETHEMA/GEM (Programa para el Estudio de la Terapéutica en Hemopatías Malignas/Grupo Español de Mieloma) Cooperative Study G
Dec 20, 2011·American Journal of Clinical Pathology·Daisy AlapatRobert B Lorsbach
Jun 5, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andy C RawstronRoger G Owen
Oct 15, 2013·British Journal of Haematology·Joaquin Martinez-LopezUNKNOWN GEM (Grupo Español Multidisciplinar de Melanoma)/PETHEMA (Programa para el Estudio de la Terapéutica en Hemopatías Malignas)
Jan 15, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark RoschewskiOla Landgren
Dec 17, 2014·Nature Reviews. Clinical Oncology·Jesús F San-Miguel, Hagop M Kantarjian
Jan 27, 2015·Cytometry. Part B, Clinical Cytometry·Maria ArrozBruno Paiva
Jan 28, 2015·Nature Reviews. Clinical Oncology·Sham MailankodyOla Landgren
Apr 25, 2015·Cytometry. Part B, Clinical Cytometry·Maryalice Stetler-StevensonAndy C Rawstron
Jun 23, 2015·Blood Reviews·María-Victoria MateosJesús F San Miguel
Jul 24, 2015·Cytometry. Part B, Clinical Cytometry·Teri A OldakerDavid Barnett
Jul 24, 2015·Cytometry. Part B, Clinical Cytometry·Andy C RawstronMaryalice Stetler-Stevenson
Mar 4, 2017·Cytometry. Part B, Clinical Cytometry·Katayoon JafariAnna Porwit

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
FACS
stem
leukapheresis

Software Mentioned

Kaluza
Excel
Kaluza Analysis
SOP Guard

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.